GPC Biotech, Inc.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C07K PEPTIDES 3133
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 2165
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 2204
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
6355774 Isolated p27 proteinMay 09, 97Mar 12, 02[C07K]
6316208 Methods for determining isolated p27 protein levels and uses thereofFeb 03, 97Nov 13, 01[G01N]
6242575 Antibodies for detecting p27 proteinFeb 21, 97Jun 05, 01[G01N, C07K]
5756671 CDC37 cell-cycle regulatory protein, and uses related theretoApr 01, 96May 26, 98[C07K]
5744343 Ubiquitin conjugating enzymesSep 13, 94Apr 28, 98[C07H, C12N]
5688665 Isolated nucleic acid molecules encoding the p27 KIP-1 proteinJul 15, 94Nov 18, 97[C12N]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
7135550 Three hybrid assay systemExpiredSep 03, 02Nov 14, 06[C12Q]
2005/0090,471 Inhibitors of cyclin-dependent kinases, compositions and uses related theretoAbandonedOct 04, 04Apr 28, 05[A61K, C07D]
2004/0235,798 Compositions and methods for inhibiting prenyltransferasesAbandonedMay 07, 04Nov 25, 04[A61K]
6753329 Inhibitors of cyclin-dependent kinases, compositions and uses related theretoExpiredDec 17, 02Jun 22, 04[A61K, C07D, A61P]
6747128 Components of ubiquitin ligase complexes, and uses related theretoExpiredAug 20, 97Jun 08, 04[C12N, C07K]
6635450 Isolated P27 protein, nucleic acid molecules encoding same, methods of identifying agents acting on same, and uses of said agentsExpiredApr 28, 97Oct 21, 03[C12N]
2003/0165,873 Three hybrid assay systemAbandonedMar 04, 02Sep 04, 03[C07H, C12Q, G01N, C07K, C07J]
2003/0166,004 Endothelial-cell binding peptides for diagnosis and therapyAbandonedNov 01, 02Sep 04, 03[A61K, C07H, C12P, C12N, G01N, G06F]
2003/0157,477 Methods and reagents for identifying synthetic genetic elementsAbandonedSep 12, 01Aug 21, 03[C12Q, C12N]
2003/0104,362 CELL-CYCLE REGULATORY PROTEINS FROM HUMAN PATHOGENS, AND USES RELATED THERETOAbandonedMay 05, 98Jun 05, 03[C07H, C12Q, C12N]
6521602 Anti-neoplastic compositions and uses thereofExpiredMar 01, 00Feb 18, 03[A61K, C12N]
6495526 Inhibitors of cell-cycle progression and uses related theretoExpiredJul 29, 97Dec 17, 02[A61K, C07H]
2002/0172,940 Methods and reagents for isolating biologically active peptidesAbandonedFeb 22, 02Nov 21, 02[C12Q, G01N, C07K]
6455281 Nucleic acids for identifying anti-fungal agents, and uses related theretoExpiredDec 20, 96Sep 24, 02[C12N]
2002/0107,226 ASSAYS AND REAGENTS FOR IDENTIFYING ANTI-FUNGAL AGNETS, AMD USES RELATED THERETOAbandonedJul 22, 99Aug 08, 02[A61K, A01N]
6420110 Methods and reagents for isolating biologically active peptidesExpiredOct 19, 98Jul 16, 02[C12Q, C12P, C12N, G01N]
6420345 Methods and reagents for inhibiting angiogenesisExpiredDec 09, 99Jul 16, 02[A61K, C07H, C12N]
6413943 Methods and reagents for inhibiting proliferation of smooth muscle cellsExpiredDec 09, 99Jul 02, 02[A61K, C07H, C12N]
2002/0048,571 Chimeric polypeptides of serum albumin and uses related theretoAbandonedJan 23, 01Apr 25, 02[A61K, C12N]
2001/0056,075 Chimeric polypeptides of serum albumin and uses related theretoAbandonedJan 18, 01Dec 27, 01[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.